Study: Commercially available antibodies used to investigate modification of key cancer braking mechanism aren’t fully reliable

College basketball fans have March Madness. But for fans of medical research, there’s nothing like STAT Madness, an online tournament of science run by the STAT health news organization.

Improving outcomes for pancreatic cancer patients has been a long, slow road, but Michigan Medicine doctors are staying the course and are developing new methods of treatment for the disease.

Research behind a drug compound that causes complete remission of a leukemia subtype in mouse models has recently spurred a human clinical trial.

Glioblastoma is a deadly brain cancer with little treatment options available, but Michigan Medicine researchers are working in the lab to change that.

New research suggests that when embryonic stem cells are exposed to certain proteins during development influences what kind of cells they will become.

Data on discrimination experienced by physicians

Research suggests the possibility of a more general phenomenon, applicable to the growth of other primary cell types.

In mouse models, the work uncovers a new potential target to improve immunotherapy approaches to the deadly disease.

Research suggests wearable temperature monitors may offer an inexpensive, non-invasive way to detect a life-threatening bone-marrow transplant complication.

A U-M law student, who passed of breast cancer in 2019, is remembered by her family and school in a special way.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.

The University of Michigan Rogel Cancer Center’s Top 10 stories of 2019.

After being diagnosed with an aggressive brain tumor, Kathy Bellmore has outlived her initial prognosis, and is going strong.

A cancer diagnosis can lead to a lot of questions. Here are five essential things you need to know about cancer.